US Broker Ratings

Claritev Corporation (CTEV): Investor Outlook Highlights 21% Potential Upside Amidst Growth in Healthcare Data Solutions

Investors looking for opportunities in the healthcare technology sector may find Claritev Corporation (NASDAQ: CTEV) an intriguing prospect. Specializing in data analytics and cost management solutions..

Community Health Systems, Inc. (CYH): Investor Outlook on Healthcare Stock with Mixed Analyst Sentiment

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of medical facilities across the United States. Headquartered in..

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: A 304% Potential Upside Awaits Investors in the Biotech Arena

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is grabbing investor attention with its promising pipeline and significant potential upside. Based in Gaithersburg, Maryland, Altimmune focuses on..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring an 86% Upside Potential with Analyst Confidence

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with an impressive market capitalization of $1.02 billion. Specializing..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector’s Growth Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) represents a compelling opportunity in the healthcare sector, especially within the specialty and generic drug manufacturing industry. With a market capitalization..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Uncovering a 36% Potential Upside in Biotech

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to treating neurodegenerative diseases. With a market..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring the 231.72% Potential Upside

Investors eyeing the biotechnology sector for promising opportunities might want to take a closer look at Capricor Therapeutics, Inc. (NASDAQ: CAPR). With a market capitalization of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 8.46% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in senior care through the Program of All-Inclusive Care for the Elderly (PACE), has been capturing investor..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Biotech Gamble with a 366% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial-stage biopharmaceutical company, stands at the forefront of developing innovative cell therapies for treating metastatic melanoma and other solid tumor..

LENZ Therapeutics, Inc. (LENZ)

⚠️ No article content returned.

..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a 93% Potential Upside in Biotech

In the dynamic world of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) emerges as a promising player with substantial growth prospects. With its robust 93.05% potential upside,..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a 53% Potential Upside in Biotechnology

Keros Therapeutics, Inc. (NASDAQ: KROS) stands as a promising player in the biotechnology sector, drawing attention with its innovative approach to treating disorders linked to dysfunctional..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating a 69.31% Potential Upside Amidst Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services sector, is capturing investor attention with a notable potential upside of 69.31%. Despite..

HealthStream, Inc. (HSTM) Stock Analysis: Is a 38% Upside Within Reach?

HealthStream, Inc. (NASDAQ: HSTM) stands as a noteworthy contender in the Health Information Services industry, particularly for investors seeking exposure to the healthcare sector’s digital evolution...

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking a 39.86% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, has been drawing attention from investors due to its impressive potential upside and robust..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 37.10% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, has captured investor attention with its pioneering work in T cell redirecting immunotherapies. With..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring an 80% Upside Amidst Robust Revenue Growth

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology firm based in San Diego, is currently capturing the attention of investors with its promising potential upside of 80.22%...

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Biotech with a 108.94% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at the forefront of the biotechnology sector, focusing on the development of gene therapies for rare and life-threatening diseases. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds